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Abstract
Introduction—The cutaneous microbiome maintains skin barrier function, regulates 
inflammation, and stimulates wound healing responses. Burn injury promotes an excessive 
activation of the cutaneous and systemic immune response directed against commensal and 
invading pathogens. Skin grafting is the primary method of reconstructing full-thickness burns, 
and wound infection continues to be a significant complication.
Methods—In this study, the cutaneous bacterial microbiome was evaluated and subsequently 
compared to patient outcomes. Three different full-thickness skin specimens were assessed: 
1.)control skin from non-burned subjects; 2.)burn margin from burn patients; and 3.)autologous 
donor skin from the same cohort of burn patients.
Results—We observed that skin bacterial community structure of burn patients was significantly 
altered compared to control patients. We determined that the unburned autologous donor skin from 
burn patients exhibits a microbiome similar to that of the burn margin, rather than unburned 
controls, and that changes in the cutaneous microbiome statistically correlate with several post-
burn complications. We established that Corynebacterium positively correlated with burn wound 
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infection, while Staphylococcus and Propionibacterium negatively correlated with burn wound 
infection. Both Corynebacterium and Enterococcus negatively correlated with the development of 
sepsis.
Conclusions—This study identifies distinct differences in the cutaneous microbiome between 
burn subjects and unburned controls, and ascertains that select bacterial taxa significantly correlate 
with several co-morbid complications of burn injury. These preliminary data suggest that grafting 
donor skin exhibiting bacterial dysbiosis may augment infection and/or graft failure and sets the 
foundation for more in-depth and mechanistic analyses in presumably “healthy” donor skin from 
patients requiring skin grafting procedures.
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Introduction
The cutaneous microbiome exists as a diverse community capable of maintaining skin 
barrier function, regulating inflammation, and promoting wound healing responses (1–3). 
The pathophysiology of burn injury to the skin suggests an excessive activation of the 
cutaneous and systemic immune responses targeted against commensal and invading 
pathogens post-injury. It is interesting to theorize that, in some patients, a shift in the 
colonizing microbiota of the skin may provoke and propagate primary and secondary 
complications in burn patients, leading to increased morbidity and mortality. The 
identification of a “pathogenic” microbiota could lead to early diagnostic tools that may be 
able to predict infection risk or wound healing delays in burn subjects. Individuals with 
substantial burn injuries exhibit more diverse responses, as compared to other types of 
traumatic injury. For example, burn subjects exhibit greater morbidity than predicted using 
the injury severity scoring system (4), and they demonstrate a greater prevalence of sepsis 
and mortality (5, 6). These outcomes suggest that the destruction of the cutaneous barrier 
caused by severe burn injury may be provoking a unique impact on local and distal tissues, 
leading to increased morbidity and mortality. These outcomes are partially attributed to 
disturbances in the skin, including changes in innate immune function and the resident 
microbiota (7–9).
Skin grafting is the predominant method of reconstructing full-thickness burns. Autologous 
grafts from distal, unburned skin often exhibit functional deficiencies and tissue breakdown 
after grafting. Burn wound infection at both the donor and burn site remain a frequent and 
serious complication of major burn injury and account for over 50% of all deaths related to 
burn injury (6, 10, 11). We recently determined that epidermal lipid and antimicrobial 
peptide (AMP) responses are impaired in both donor skin and burn margin from human burn 
patients (12). These alterations in epidermal barrier function demonstrate that traumatic burn 
injury elicits a global change in the antimicrobial function of presumably normal skin, which 
would serve as donor skin for burn patients. Thus, after burn injury, the cutaneous 
microbiota is likely altered in donor skin, and may also be a source of graft failure, burn 
wound infections, and/or subsequent infectious complications in burn patients.
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To our knowledge, the impact of burn injury on the cutaneous microbiome in the context of 
skin grafting has not been evaluated. In this study, we hypothesize that unburned autologous 
donor skin from burn patients exhibits a microbiome similar to that of the burn margin, 
rather than unburned controls, and that features of the cutaneous bacterial microbiome form 
burn patients statistically correlate with several post-burn complications. We propose that the 
colonizing microbiota in the skin may be used as a tool to predict morbidity and graft failure 
in burn patients, or other patient cohorts necessitating skin grafting procedures.
Materials and Methods
Sample Collection and Clinical Information
All protocols were approved by the Institutional Review Board at Loyola University Chicago 
Health Sciences Campus. A standing approval for discarded skin was used to collect the 
tissue samples. Briefly, patients admitted to the Burn Intensive Care Unit (BICU) were 
excluded from the study under the following conditions: age < 18 years, pre-existing skin 
disease, pre-existing clinically-evident infection, previous transplant recipient, recent major 
traumatic injury <4 months prior to the burn injury, history of disseminated cancer, and/or 
pre-existing immunodeficiency. The following clinical characteristics and outcomes were 
extracted from the electronic medical records and entered into a database: age, gender, % 
total body surface area (%TBSA) injured, inhalation injury, burn injury mechanism, and 
subsequent pneumonia, urinary tract infection, graft failure, wound infection, sepsis and/or 
multisystem organ dysfunction (MODS), and mortality. Injury severity was determined 
based on %TBSA with partial and/or full thickness burns. Initial fluid resuscitation was 
directed according to the Parkland formula (4 mL / kg / % TBSA with half given during the 
first 8 hours following injury and the remaining half given over the next 16 hours), per the 
BICU standard protocol. Discarded skin samples from burn patients undergoing routine 
excision/debridement and skin grafting were obtained in the operating room. On average, the 
burn skin samples were obtained during routine surgeries (excision, debridement, and 
grafting) within 5 days post-burn. The burn margin (partial thickness) was obtained from the 
skin adjacent to the excised area of the burn and not directly in contact with the thermal 
source. Following excision of the burn wound, a 5–10 mm margin of grossly normal 
appearing skin was excised simultaneously with the wound. The wound itself was debrided 
up to the point of viable tissue to facilitate optimal wound healing in the patients, thus 
yielding viable tissue near the burn margin that was excised. Donor skin (partial thickness) 
was taken from a site distal to the original injury (autograft site), per standard surgical 
protocols. Although two burn patients required multiple surgeries, and thus contributed two 
samples for this study, none of the patients required repeat use of a specific donor site. 
Control skin samples were obtained from patients undergoing elective surgeries (e.g. breast 
reduction; panniculectomy).
Wound and Skin Care Prior to Surgery
In general, when burn patients arrive to the hospital, the wounds are immediately washed 
and manually debrided (with scrubbing) using a 4% chlorhexidine gluconate solution. The 
wounds are then typically dressed with a topical antimicrobial ointment, such as silver 
sulfadiazine, and gauze, and the dressings are routinely changed 1–2 times each day until 
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they undergo their surgical debridement; additional washings are not routine and the donor 
sites are not specifically washed with any solutions. Bacterial cultures from the burn unit are 
not routinely evaluated. Oral and/or intravenous antibiotics are not routinely administered 
unless a patient develops a clinical infection, which does occasionally happen (Table 2). 
Patients undergoing elective surgery (controls) are routinely asked to wash/shower using the 
same 4% chlorhexidine solution that is used on the burn patients, the evening prior to their 
surgery. Pre-operatively (immediately prior to surgery), similar topical antiseptic/
antimicrobial products are used on the donor skin prior to harvesting and the burn skin prior 
to debridement (both are prepped with a solution containing 4% chlorhexidine gluconate), as 
compared to the skin from controls (prepped with a solution containing 2% chlorhexidine 
gluconate and 70% isopropyl alcohol).
Bacterial Microbiome Analysis
For all analyses, skin specimens were frozen at −80°C until microbial DNA isolation and 
sequence analysis. Partial-thickness skin samples were thawed and homogenized in Assay 
Assure™. DNA was extracted from the cell pellets using a Qiagen DNeasy (Qiagen Inc., 
Valencia CA) tissue extraction kit. Genomic DNA was eluted in nuclease-free water and 
stored at 4°C until 16S rRNA PCR amplification and sequencing. The V1–V3 region 16S 
rDNA PCRs included 2 μl of skin gDNA preparation, Phusion high fidelity DNA 
polymerase (New England Biolabs, Ipswich, MA) and oligonucleotide primers, as 
previously described (13). Mothur software (version 1.23.0) was applied to deconvolute the 
454 sequence reads into individual samples based on complete matches to the barcode 
sequences. Primers and barcodes were clipped from each read and clipped sequences shorter 
than 200 bp were discarded. Low-quality and chimeric sequences were eliminated with 
default parameters as described in the Mothur’s standard operating procedure (http://
www.mothur.org/wiki/454_SOP) (14). Taxonomic classification (from phylum to genus 
level) of the sequence reads was conducted by the Ribosomal Database Project Classifier 
(version 2.4) with the default 0.8 confidence threshold (15). In total, 37,734 high-quality 
reads were obtained from 25 samples (1509±683.8). To minimize unequal sampling effects, 
subsampling without replacement was performed to randomly extract 750 reads from each 
sample. The process was then repeated 10 times and the average taxonomic count was 
employed for subsequent statistical analysis. Microbial diversity indices were calculated 
from subsampled sequence data, which was performed by subsampling without replacement 
of 1000 reads from each sample for 1000 times (if a sample contains less than 1000 reads in 
total, all of its reads were used for analysis without subsampling) to avoid any bias caused 
by the various sequencing depths of samples, as described previously (16, 17). Analyses of 
the bacterial abundance between each cohort was performed using the metagenomeSeq 
package with a built-in multiple test correction (18). We determined correlations using 
numerous diversity indices (S. chao1; S. ACE; Shannon; Simpson; Eveness; Inverse 
Simpson). All statistical tests were performed using the R software environment (http://
www.r-project.org). All of the sequences and associated metadata were deposited to the 
NCBI Sequence Read Archive under the BioProject ID is PRJNA293586.
Mock specimens were processed in parallel with skin specimens to monitor for reagent 
contamination. PCR Amplicons were purified by Qiaquick gel extraction kit (Qiagen) and 
Plichta et al. Page 4
Shock. Author manuscript; available in PMC 2018 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
quantified by Quant-It HS double stranded DNA assay (Invitrogen, Carlsbad CA). Emulsion 
PCR and 454 library generation steps were performed according to the manufacturer’s 
protocol (454 Life Sciences). Sequencing was performed on a Roche/454 GS-FLX Titanium 
system at the Indiana University Center for Genomics and Bioinformatics, Bloomington, IN. 
All p values reported were corrected for multiple tests with the Benjamini-Hochberg 
procedure. Bray-Curtis dissimilarity was visualized using non-metric dimensional scaling 
(NMDS), a non-parametric ordination approach based on rank-order. All of the sequences 
and associated metadata were deposited to the NCBI Sequence Read Archive under the 
BioProject ID is PRJNA293586.
Results
Patient Demographics and Clinical Morbidities
Skin samples from 9 BICU patients (including males and females) aged 20–54 years were 
evaluated (median age: 47). The median total burn surface area (TBSA) in the study group 
was 35% (range 11–52%). Of the 9 burn patients studied, 44% (n = 4) developed 
pneumonia, 55% (n = 5) suffered a wound infection of the donor or burn site, and 44% (n = 
4) were treated for blood culture positive sepsis. Patients with no cutaneous burn were 
excluded (Table 1). The mortality rate was 20% (n = 1) for all patients in the study group; 
the individual who succumbed to their injury was 53 years old and had a 52% TBSA burn 
injury. Of the 9 burn patients studied, 44% (n = 4) were admitted for a scald burn, while 
55% (n = 5) were admitted for a flame burn (Table 2). Control skin samples were obtained 
from 9 non-burned volunteers aged 18–51 years (median age: 45). All patients (burn and 
control) received intravenous antibiotics prior to surgery (Table 2), which was determined 
based on several standard patient/clinical factors (including current/recent infections, 
allergies, etc.).
Burn Injury Augments Microbial Diversity
Burn subjects colonized with distinct microbiota will presumably develop secondary 
complications, which may contribute to graft failure or infection. To test this hypothesis, we 
used non-metric multidimensional scaling (NMDS) based on Bray-Curtis dissimilarity to 
first demonstrate that the bacterial microbiome in both donor skin and burn margin was 
significantly different than non-burned control skin (Figure 1A) (PERMANOVA test 
p<0.002, either with or without considering age, gender, and ethnic group as confounding 
factors in the test). Based on 16S rDNA sequences, most skin bacteria were classified into 
four phyla: Actinobacteria, Bacteroides, Firmicutes and Proteobacteria, similar to previous 
reports of the skin microbiome (3, 19). The results of this phyla level composition is to very 
broadly compare our results with previously published skin microbiome studies (2, 3, 19, 
20) and demonstrate that our dataset in burn subjects falls within the expected range of the 
bacterial phylogeny that are typically present on the skin. However, we do not assume that 
taxa within a phylum stimulate similar clinical responses. We next determined whether 
different bacterial taxa are enriched in donor skin and burn margin compared to control skin 
by analyzing genera abundance using a negative binomial mixed-effect model (taxa 
abundance was the response variable; skin type was the explanatory variable with age, 
gender and ethnic group as confounding factors; subjects were treated as the random effect 
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in the mixed model to account for intra-subject correlations). (Figure 1B). Donor skin and 
burn margin were enriched with several taxa in comparison to control skin, including 
Aeribacillus (p<0.005 and p<0.03, respectively), Caldalkalibacillus, (p<0.02 and p<0.02, 
respectively) and Nesterenkonia (p<0.004 and p<0.0007, respectively). These taxa are 
similar in that they are extremophiles, specifically thermophilic or halophilic (21–23), and 
have not been extensively associated or studied in the context of pathogenesis in humans. In 
contrast, Corynebacterium, a widespread skin commensal, was significantly lower in both 
donor skin and burn margin relative to control skin (p<0.001 and p<0.02, respectively). Of 
note, since innate differences in community structure/membership of skin sites exist (19), we 
ensured that the control sites matched the general microenvironment of the donor sites. A 
summary of the genera determined to be statistically more or less abundant between each 
cohort is represented in Table 3.
Microbial Diversity Correlates with Clinical Outcomes after Burn Injury
We next assessed whether skin bacterial taxa significantly correlated with the following co-
morbid complications of burn injury (Table 4): pneumonia (n = 3), wound infection (n = 7) 
and sepsis (n = 6) using a negative binomial model (response variable being each type of co-
morbid complications of burn injury, explanatory variable being the skin types, with age, 
gender and ethnic group as confounding factors). Five taxa in the burn margin were 
correlated with the development of pneumonia in burn subjects: Propionibacterium 
(negatively correlated, p= 0.00134), Aeribacillus (positively correlated, p=0.0297), 
Nesterenkonia (positively correlated, p=0.000358), Halomonas (positively correlated, 
p=0.000319), Sediminibacterium (positively correlated, p=0.00112), with Nesterenkonia 
being the most abundant genera enriched in those patients with pneumonia (14.91%). Three 
taxa in the burn margin were correlated with wound infection: Corynebacterium (positively 
correlated, p=0.00573), Staphylococcus (negatively correlated, p=0.00112), and 
Propionibacterium (negatively correlated, p=0.0261), with Corynebacterium being the most 
abundant genera enriched in those patients with wound infections (15.76%). Two taxa in the 
burn margin were negatively correlated with the development of sepsis: Corynebacterium 
(p=0.0231) and Enterococcus (p=0.000296), with Corynebacterium being the most abundant 
genera enriched in those patients without sepsis (7.84%).
Discussion
The intricate pathophysiology of burn injury stimulates major local and systemic effects 
mediated by the initial inflammatory response, thus influencing global skin function and the 
resident microbiota. In this study, we introduce the first assessment of the cutaneous 
bacterial community in burn subjects, a cohort of trauma patients with a high risk of 
morbidity and mortality. We were able to capture distinct features of the microbiome in both 
donor skin and burn margin from burn subjects, which significantly differ from unburned 
controls and correlate with infectious outcomes.
We recently determined that epidermal AMP responses (e.g. protein levels and activity) are 
impaired in both donor skin and burn margin from human burn patients, which likely 
influences, or is influenced by, changes in the resident skin microbiota (12). Several skin 
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pathogens (e.g. Staphylococcus aureus) are known to induce antimicrobial molecules and 
pro-inflammatory cytokine production through cutaneous innate immune receptors, such as 
Toll-like Receptors (TLRs), and are the predominant species associated with skin wound 
infections. In parallel, resident commensal microbes (e.g. Staphylococcus epidermidis; 
Propionibacterium acnes) help maintain epidermal homeostasis by minimizing pro-
inflammatory cytokine release after skin injury (24–26) or by undergoing fermentation to 
restrict the overgrowth of other commensal bacteria (27). We observed in this study that a 
lower abundance of skin Propionibacterium correlated with a greater risk of pneumonia and 
wound infection in burn patients. Several skin pathologies and chronic wounds suggest an 
imbalance of this microbiota, without evidence of a clinical infection (2, 20). 
Corynebacterium and Propionibacterium, both prevalent members of Actinobacterium, were 
previously shown to be inversely correlated with non-resolvers and resolvers of pustule-
forming skin infections, respectively (28). Thus, these bacterial shifts likely promote subtle 
changes in skin function and immune defense at the burn site, which precipitate more robust 
complications observed in our patient population, including pneumonia, wound infection, 
and sepsis.
Interestingly, we observed that Aeribacillus, Caldalkalibacillus, Nesterenkonia, Halomonas, 
were enriched in the burn margin and/or donor skin. These taxa are analogous in that they 
are extremophiles, specifically thermophilic or halophilic, and tend to be isolated from soil 
and water sources (21–23). Of these, only Halomonas has been reported as pathogenic, 
causing bacteremia and peritonitis in dialysis centers (29, 30). We speculate that enrichment 
of these taxa may be partially derived from external exposure to hospital water (e.g. steam) 
sources following debridement procedures. We previously determined that burn injury 
significantly impairs normal skin barrier function in autologous donor skin in mice and in 
humans, which may facilitate invasion by these bacterial taxa during debridement 
procedures. However, our bacterial microbiome analysis includes full thickness skin samples 
(e.g. epidermal and dermal reservoirs), rather than only an external swab, and control 
samples did exhibit these taxa, but at a lower abundance. Thus, alternatively, cutaneous 
shifts in osmolarity caused by disruption of the local ionic environment after burn injury 
may facilitate their proliferation by providing nutrients that are normally limited in the skin. 
Both of these scenarios warrant further investigation as a mechanism to explain the positive 
correlation between these taxa and the development of pneumonia in our burn patient 
population.
Our findings suggest that the colonizing microbiota may be a useful biomarker to predict 
morbidity in burn subjects, but must be confirmed in subsequent studies with larger 
populations and a longitudinal assessment. Due to the relatively small sample size, we 
cannot consider various cofounding factors such as gender and race and sampling locations. 
However, even in a cohort of 242 subjects analyzed by the NIH Human Microbiome Project, 
only 1 taxa at 1 skin site (the antecubital fossa) was found to be differ significantly across 
races at the substantial FDR of q<0.2. Gender and other aspects of host phenotype were not 
found to statistically correlate with skin taxa in this large cohort (31).
Graft failure due to poor wound healing or infection remains a significant problem for 
subjects necessitating skin grafts. Because skin grafting is the predominant method of 
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reconstructing a defect in the skin, and is commonly used for the reconstruction of other skin 
pathologies (e.g. chronic ulcers, cutaneous malignancies), these data suggest that the 
bacterial microbiota in the donor skin may predict how well the graft site heals or resists 
pathogenic infection. Thus, grafting donor skin exhibiting bacterial dysbiosis may increase 
the risk for infection and/or graft failure in any patient requiring skin grafting. As such, 
treatment of donor skin with probiotics or prebiotics prior to grafting may improve patient 
outcomes. By increasing the abundance of “protective” bacteria on the skin prior to grafting, 
the time needed for the skin to regain its baseline barrier function may be significantly 
shortened. One study utilized topical Lactobacillus after various degrees of burn injury in 
humans, but the outcomes were not robust in terms of promoting healing and reducing 
infection (32). Our study indicates alternative bacterial taxa (e.g. Propionibacterium), which 
may be potential targets for topical “probiotics” to improve healing and limit secondary 
complications in burn subjects. Although the optimal “protective” bacterial profile remains 
elusive, the identification of novel mechanisms for shifts in the cutaneous microbiota after 
burn injury, or after traumatic injury in general, could prove rather beneficial. Specifically, 
further studies can potentially elucidate both the source of the distinct microbiota (e.g. 
steam; topical agents) and the molecular mechanisms by which a shift in the microbiota 
profile occurs in burn margin and autologous donor skin in burn subjects. There is the 
possibility that bathing and other hygienic activities conducted during hospitalization may 
influence the skin microbiome. However, recent work has demonstrated that the skin 
microbiome is stable over the long term despite these perturbations (33). Specifically, little 
to no effect on resident microbiota was observed after topical administration of soaps (34). 
Furthermore, chlorhexidine washes, which are broad spectrum antiseptic treatments, do not 
select for specific populations in the same way that antibiotics may. In our study, both 
controls and burn subjects were subjected to similar chlorhexidine compositions. While 
bacterial load is effectively reduced with these treatments, they do not change the 
composition or diversity of the skin microbiome. Our burn margin, donor sites, and control 
samples are partial-thickness samples (rather than skin swabs) comprised mostly of 
epidermis. Thus, our microbiome analysis will identify bacteria typically found within the 
epidermis and upper dermis. Future studies are necessary to identify temporal changes in the 
microbiome in burn patients, which will assess the stability of the cutaneous microbiome 
over the following year (s), as the patient continues to heal from their injuries. It is also 
possible that the skin microbiome of the burn patients is inherently transferred to their 
caregivers, and needs further exploration. It would also be of interest to investigate whether 
the loss of epidermis at the donor site after donor skin harvest will impact the developing 
microbiome over time, relative to other non-burned sites that contain epidermis, to assess 
whether it is the absence of epidermis or a local response to the burn/grafting that alters the 
microbiome.
Because it may take 1–2 days to evaluate a burn patient’s cutaneous microbiome by 16S 
rRNA gene sequencing, this information would not likely be rapidly available for inclusion 
in a Burn Injury Severity Score (BISS). However, it could potentially be used at a later time 
as an adjunct to the BISS to provide a modified score for subsequently predicting a patient’s 
prognosis. Expanded culture techniques may also be used to cultivate live bacteria from 
these patients, as bacterial genomic sequencing and expanded bacterial culture techniques 
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are emerging as critical complementary tools to identify bacterial dysbiosis under 
pathological conditions (35, 36). Controlling dramatic changes in the skin microbiota 
immediately after burn injury may have systemic implications, as the burn wound serves as 
the foundation for most of the secondary immune and wound healing responses and co-
morbidities. These preliminary studies suggest that grafting donor skin exhibiting bacterial 
dysbiosis may augment infection and/or graft failure in patients necessitating skin grafting 
procedures, and sets the foundation for more in-depth and mechanistic analyses in 
presumably “healthy” donor skin from burn patients.
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Figure 1. 
NMDS plot of control skin vs. donor skin and burn margin (A) demonstrates the impact of 
burn injury on the overall cutaneous bacterial microbiome. Control skin (CS) (green), N=9; 
donor skin (DS) (red), N=7; Burn margin (BM) (black), N=9. (B) The most abundant 
bacterial genera in control skin, donor skin, and burn margin skin are indicated in horizontal 
bar graphs. * indicates genera in donor skin and burn margin that are significantly enriched 
as compared to control skin. # indicates genera in donor skin and burn margin that are 
significantly deficient as compared to control skin.
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Table 3
The bacterial genera demonstrating a statistically significant difference in the relative abundance between 
different skin sites are shown. CS= control skin; DS= donor skin; BM= burn margin. Pairwise comparisons 
were performed between these three locations. A negative binomial mixed effect model was applied with age, 
gender, and race as confounding factors. The multiple test correction was applied to the P values with 
Benjamin-Hochberg procedure. The average relative abundance and the standard deviation from different skin 
communities of each interested genera are shown in the table.
Genera Corrected P value Average relative abundance in CS 
(standard deviation)
Average relative abundance in DS 
(standard deviation)
CS vs. DS
Cloacibacterium 4.92E-09 2.47% (3.93%) 0.05% (0.06%)
Corynebacterium 6.53E-06 52.13% (31.66%) 2.91% (2.84%)
Diaphorobacter 7.53E-06 4.30% (5.00%) 0 (0)
Nesterenkonia 0.000730168 1.61% (1.80%) 14.43% (10.80%)
Aeribacillus 0.003681914 3.86% (4.89%) 24.71% (19.31%)
Hydrogenophilus 0.011783222 2.73% (4.03%) 0.20% (0.48%)
Caldalkalibacillus 0.018756316 0.48% (0.48%) 3.01% (2.19%)
CS vs. BM
Genera Corrected P value Average relative abundance in CS (standard deviation)
Average relative abundance in BM 
(standard deviation)
Cloacibacterium 2.10E-20 2.47%(3.9%) 0.18% (0.24%)
Diaphorobacter 1.71E-05 4.35% (5.00%) 0.31% (0.34%)
Nesterenkonia 0.005316297 1.61% (1.80%) 11.36% (8.54%)
Corynebacterium 0.028968988 52.13% (31.66%) 11.16% (11.18%)
Aeribacillus 0.028968988 3.86% (4.89%) 16.85% (11.01%)
Hydrogenophilus 0.028968988 2.73% (4.03%) 0.33% (0.48%)
Caldalkalibacillus 0.028968988 0.48% (0.48%) 2.04% (1.83%)
DS vs. BM
Genera Corrected P value Average relative abundance in DS 
(standard deviation)
Average relative abundance in BM 
(standard deviation)
Lactobacillus 5.86E-06 0.18% (0.33%) 1.03% (1.40%)
Corynebacterium 0.010124178 2.91% (2.84%) 11.16% (11.18%)
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Table 4
Significant correlations between genera within the skin bacterial community structure of burn margin (BM) 
and patient co-morbidities (i.e. pneumonia, wound infection, and Sepsis). A negative binomial mixed effect 
model was applied with age, gender, and race as confounding factors. The multiple test correction was applied 
to the P values with Benjamin-Hochberg procedure. The average relative abundance and the standard deviation 
of the interested genera in different patient co-morbidities cohorts are shown in the table.
Genera Corrected P value Average relative 
abundance in Pneumonia
+ (standard deviation)
Average relative 
abundance in Pneumonia
− (standard deviation)
Pneumonia+ vs. pneumonia− 
(BM)
Nesterenkonia 0.000407149 14.91% (9.36%) 8.52% (7.60%)
Halomonas 0.000407149 3.55% (3.28%) 0.17% (0.22%)
Propionibacterium 0.001468212 3.86% (0.91%) 23.96% (34.23%)
Sediminibacterium 0.001433633 2.86% (3.00%) 0.79% (1.03%)
Aeribacillus 0.035263334 21.20% (12.26%) 13.37% (9.77%)
Wound infection+ vs. Wound 
infection− (BM)
Genera Corrected P value Average relative 
abundance in Infection+ 
(standard deviation)
Average relative 
abundance in Infection− 
(standard deviation)
Staphylococcus 0.001029655 5.00% (3.97%) 9.15% (15.30%)
Corynebacterium 0.007617801 15.76% (12.46%) 5.41% (6.84%)
Propionibacterium 0.028735336 5.79% (5.31%) 26.58% (38.79%)
Sepsis+ vs. sepsis− (BM)
Genera Corrected P value Average relative 
abundance % in Sepsis+
(standard deviation)
Average relative 
abundance % in Sepsis− 
(standard deviation)
Sepsis+ vs. sepsis− (BM) Enterococcus 0.000249211 0.32% (0.32%) 1.12% (1.12%)
Corynebacterium 0.027060777 7.84% (12.08%) 13.81% (13.81%)
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